These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 543247)

  • 1. [Chronic arterial occlusive disease: early and late results after semi-ambulatory treatment with serpent enzyme (Arvin)].
    Staiger J; Hausch W; Keil G; Konrad S
    Vasa; 1979; 8(4):314-9. PubMed ID: 543247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 3. [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course].
    Heidrich H
    ZFA (Stuttgart); 1978 Nov; 54(32):1648-51. PubMed ID: 735320
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with Arvin therapy in aged patients].
    Landgraf H; Stumpf J; Knecht H; Raithel D
    Ther Ggw; 1979 Mar; 118(3):375-86. PubMed ID: 432855
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modified dosage scheme for the subcutaneous use of arvin in patients with chronic arterial occlusive diseases].
    Ehrly AM; Köhler HJ
    Vasa; 1976; 5(2):155-62. PubMed ID: 973426
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arvin--a new therapeutic agent].
    Ehrly AM
    Med Welt; 1978 Jul; 29(27-28):1144-5. PubMed ID: 672584
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
    Staiger J; Konrad-Graf S; Keil G
    Bibl Haematol; 1981; (47):252-7. PubMed ID: 7337665
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of peptic ulcer in an inpatient angiologic patient sample].
    Creutzig A; Horstkotte H; Fischer M; Kleine P; Brunner G; Alexander K
    Leber Magen Darm; 1984 Jul; 14(4):161-3. PubMed ID: 6482641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indication for arvin therapy from a surgical viewpoint].
    Stockmann U
    ZFA (Stuttgart); 1978 Nov; 54(32):1652-3. PubMed ID: 735321
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J; Spaan G; Stein U; Wagner E; Frese JH
    Med Klin; 1979 Sep; 74(39):1396-403. PubMed ID: 492058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Defibrination in the therapy of arterial occlusive diseases].
    Böhme H
    ZFA (Stuttgart); 1978 Nov; 54(32):1644-7. PubMed ID: 735319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H; Schmidt P; Hüttel E
    MMW Munch Med Wochenschr; 1978 Nov; 120(45):1501-4. PubMed ID: 101819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with Arwin (author's transl)].
    Hess H; Keil-Kuri E; Marshall M
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1317-20. PubMed ID: 819792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H; Dudczak R; Lechner K
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired resistance to prolonged treatment with intravenous "Arvin" (ancrod).
    Thomson NC; Hutcheon AW; Dagg JH
    Br J Clin Pract; 1976; 30(11-12):232-3. PubMed ID: 1008987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of peripheral occlusive arteriopathies. Possibilities, principles and basis].
    Heidrich H
    Minerva Med; 1979 Oct; 70(47):3255-63. PubMed ID: 390422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.